China Universal Asset Management Company’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$388K Sell
13,433
-1,545
-10% -$41.7K 0.02% 286
2026
Q1
$271K Buy
14,978
+1,258
+9% +$24K 0.02% 325
2025
Q4
$298K Sell
13,720
-1,039
-7% -$29.8K 0.02% 303
2025
Q3
$481K Sell
14,759
-1,647
-10% -$60.8K 0.04% 252
2025
Q2
$582K Buy
16,406
+21
+0.1% +$680 0.05% 229
2025
Q1
$556K Sell
16,385
-935
-5% -$33.5K 0.05% 239
2024
Q4
$564K Buy
17,320
+1,609
+10% +$66.6K 0.05% 240
2024
Q3
$766K Buy
15,711
+6,114
+64% +$326K 0.08% 166
2024
Q2
$425K Sell
9,597
-5,695
-37% -$263K 0.06% 159
2024
Q1
$858K Buy
15,292
+6,070
+66% +$366K 0.11% 138
2023
Q4
$555K Buy
9,222
+7,174
+350% +$455K 0.11% 139
2023
Q3
$138K Buy
2,048
+1,199
+141% +$83.3K 0.04% 171
2023
Q2
$58.6K Sell
849
-29
-3% -$1.9K 0.02% 180
2023
Q1
$42.3K Buy
878
+220
+33% +$10.8K 0.01% 161
2022
Q4
$32.8K Buy
658
+159
+32% +$7.7K 0.01% 154
2022
Q3
$20K Buy
+499
New +$23.4K 0.01% 157

Other funds holding LEGN

China Universal Asset Management Company's LEGN Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Legend Biotech (LEGN) stake by 10% in Q2 2026, selling an estimated $41.7K and leaving 13,433 shares worth $388K. The position accounts for 0.02% of the portfolio, ranked #286.

China Universal Asset Management Company first reported a position in LEGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $858K in Q1 2024. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • China Universal Asset Management Company held 13,433 shares of Legend Biotech worth $388K as of Q2 2026.
  • China Universal Asset Management Company sold 1,545 Legend Biotech shares in Q2 2026, an estimated $41.7K.
  • Legend Biotech made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #286 holding.
  • China Universal Asset Management Company first reported a position in Legend Biotech in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Legend Biotech position peaked at $858K in Q1 2024.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.